| Literature DB >> 214030 |
J P Rissing, C Newman, W L Moore.
Abstract
Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole therapy. Metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.Entities:
Mesh:
Substances:
Year: 1978 PMID: 214030 PMCID: PMC352522 DOI: 10.1128/AAC.14.4.636
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191